நடவடிக்கைகள் ப்ரைமரீ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

According to a study published in
JAMA today, researchers from the Centro de Estudios en Infectologia Pediatrica in Cali, Colombia looked at the effect of Ivermectin on time to resolution of symptoms among adults with mild COVID-19.
Abstract
Image/CDC
Importance  Ivermectin is widely prescribed as a potential treatment for COVID-19 despite uncertainty about its clinical benefit.
Objective  To determine whether ivermectin is an efficacious treatment for mild COVID-19.
Design, Setting, and Participants  Double-blind, randomized trial conducted at a single site in Cali, Colombia. Potential study participants were identified by simple random sampling from the state’s health department electronic database of patients with symptomatic, laboratory-confirmed COVID-19 during the study period. A total of 476 adult patients with mild disease and symptoms for 7 days or fewer (at home or hospitalized) were enrolled between July 15 and November 30, 2020, and fo ....

Infectologia Pediatrica , Centro De Estudios , Participants Double Blind , Measures Primary , Relevance Among , சிஇஎன்டிஆர்ஓ டி ெஸ்த்துதிோஸ் , நடவடிக்கைகள் ப்ரைமரீ , சம்பந்தம் மத்தியில் ,